Evidence map›Paper›PMID 38004777›Full record

ArticleMicroorganisms2023

Risk Assessment for the Spread of Flavescence Dorée-Related Phytoplasmas from Alder to Grapevine by Alternative Insect Vectors in Germany.

Barbara Jarausch, Anna Markheiser, Wolfgang Jarausch, Sandra Biancu, Sanela Kugler, Miriam Runne, Michael Maixner

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Insects · 2024
    Article
  7. Investigating a new alarming outbreak ofFrontiers in plant science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Barbara JarauschJulius Kühn Institute, Federal Research Centre for Cultivated Plants, Institute for Plant Protection in Fruit Crops and Viticulture, Geilweilerhof, 76833 Siebeldingen, Germany.ORCID 0000-0001-7729-3014
Anna MarkheiserJulius Kühn Institute, Federal Research Centre for Cultivated Plants, Institute for Plant Protection in Fruit Crops and Viticulture, Geilweilerhof, 76833 Siebeldingen, Germany.ORCID 0000-0002-5775-4909
Wolfgang JarauschRLP AgroScience, Breitenweg 71, 67435 Neustadt an der Weinstrasse, Germany.
Sandra BiancuJulius Kühn Institute, Federal Research Centre for Cultivated Plants, Institute for Plant Protection in Fruit Crops and Viticulture, Geilweilerhof, 76833 Siebeldingen, Germany.
Sanela KuglerJulius Kühn Institute, Federal Research Centre for Cultivated Plants, Institute for Plant Protection in Fruit Crops and Viticulture, Geilweilerhof, 76833 Siebeldingen, Germany.
Miriam RunneRLP AgroScience, Breitenweg 71, 67435 Neustadt an der Weinstrasse, Germany.
Michael MaixnerJulius Kühn Institute, Federal Research Centre for Cultivated Plants, Institute for Plant Protection in Fruit Crops and Viticulture, Geilweilerhof, 76833 Siebeldingen, Germany.ORCID 0000-0002-2634-0308
Julius Kühn-Institut · DERLP AgroScience (Germany) · DE

Funding

INTERREG V and by funds of the Federal Ministry of Food and Agriculture (BMEL) project InvaProtect and project number 2815NA126
6 · The paper itself

Abstract

"Flavescence dorée" (FD)-related phytoplasmas are widespread in alder in Germany and their transmission to grapevine represents a high risk for FD outbreaks when the primary vector,

Indexed as

16Sr-V phytoplasmasAllygus spp.Alnus glutinosaminimum inoculation titerOrientus ishidaephytoplasma titerquantificationsurvivaltransmission capacityVitis vinifera

Identifiers

PMID38004777
PMCPMC10673178
OpenAlexW4388654310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.